Antivirals
Antivirals are compounds specifically designed to inhibit the replication and spread of viruses, playing a critical role in the treatment and prevention of viral infections. In this category, you will find a comprehensive selection of antiviral agents intended for laboratory research purposes only. These products are essential for studying viral mechanisms, developing new antiviral therapies, and understanding resistance patterns. Researchers can utilize these antivirals to investigate the efficacy and safety of potential treatments, contributing to the advancement of medical science and the development of innovative antiviral drugs. The availability of diverse antiviral agents supports cutting-edge research in virology and enhances our ability to combat viral diseases.
Found 762 products of "Antivirals"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Baloxavir marboxil
CAS:<p>Baloxavir marboxil is a selective inhibitor of the cap-dependent endonuclease of RNA polymerase, an acidic protein in influenza A and B viruses. In patients, baloxavir marboxil reduces the time to recovery by alleviating the symptoms of the influenza A and B infection, in both adults and children.</p>Formula:C27H23F2N3O7SPurity:Min. 95%Color and Shape:PowderMolecular weight:571.55 g/molRaltegravir - Bio-X ™
CAS:<p>Raltegravir is an antiretroviral agent used for the treatment of HIV infections in conjunction with other antiretrovirals. It inhibits the activity of HIV-1 integrase, which impedes the insertion of HIV-1 DNA into the host cell genome. Raltegravir also inhibits resistant mutants of HIV-1 that are associated with disease activity and progression.</p>Formula:C20H21FN6O5Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:444.42 g/molTriazavirin
CAS:<p>Triazavirin is an antiviral drug developed against SAR-CoV-2. The action of triazavirin might be due to its ability to inhibit the Mpro protease from SARS viruses. Triazavirin has been clinically tested in the treatment of COVID-19 patients.</p>Formula:C5H4N6O3S·Na·2H2OPurity:Min. 95%Color and Shape:Slightly Yellow PowderMolecular weight:287.21 g/molElbasvir
CAS:<p>Anti-viral; NS5A protein inhibitor</p>Formula:C49H55N9O7Purity:Min. 95%Color and Shape:White To Yellow SolidMolecular weight:881.42245Simeprevir
CAS:<p>Anti-viral; NS3/4A protease inhibitor_x000D_</p>Formula:C38H47N5O7S2Purity:Min. 95%Color and Shape:PowderMolecular weight:749.94 g/molLopinavir - Bio-X ™
CAS:<p>Chemically derived from ritonavir, Lopinavir belongs to the amphetamines. Lopinavir is clinically used in the prevention and treatment of HIV infections as it acts as HIV-1 protease inhibitor. In 2020, lopinavir was tested to treat COVID-19 patients and although it led to a higher rate of gastrointestinal side effects, the Lopinavir-treated group had a lower incidence of severe complications. Overall it was deemed not to work as a treatment.</p>Formula:C37H48N4O5Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:628.8 g/molDarunavir
CAS:<p>Darunavir is a HIV-1 protease inhibitor used orally in the treatment of patients with multi-drug resistant HIV-1 infection (Ghosh, 2007). It has also been shown to be effective against other infectious diseases such as hepatitis C virus and SARS coronavirus. Metabolized by cytochrome P450 3A (CYP3A) isoenzymes, darunavir is often administered together with ritonavir that prolongs its bioavaiability, giving a terminal elimination half-life (t1/2) of 15 hours (Back, 2008). The effect of darunavir on natural compounds such as matrix proteins and toll-like receptor activity has also been studied via high performance liquid chromatography (HPLC) experiments.</p>Formula:C27H37N3O7SPurity:Min. 95%Color and Shape:White PowderMolecular weight:547.66 g/molCytarabine hydrochloride - Bio-X ™
CAS:<p>Cytarabine is a pyrimidine nucleoside analogue that is used to treat leukaemia especially, non-lymphocytic leukaemia. This drug also has anti-viral and immunosuppressant properties. Cytarabine is cytotoxic and acts through direct DNA damage. Although its mechanism of action is not fully understood, it is said to inhibit DNA polymerase.</p>Formula:C9H13N3O5•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:279.68 g/molEIDD-1931
CAS:<p>Nucleoside analog with antiviral activity against coronaviruses, hepatitis and influenzas viruses. EIDD 1931 inhibited the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the murine hepatitis virus (MHV) replication in vitro at submicromolar concentrations. EIDD 1931 is able to evade the proofreading exonuclease ExoN and presents with high barrier to development of drug resistance.</p>Formula:C9H13N3O6Purity:Min. 98 Area-%Color and Shape:White Off-White PowderMolecular weight:259.22 g/molLersivirine
CAS:<p>Anti-viral; non-nucleoside reverse transcriptase inhibitor</p>Formula:C17H18N4O2Purity:Min. 95%Color and Shape:SolidMolecular weight:310.14298Rupintrivir
CAS:<p>Rupintrivir is a peptidomimetic antiviral with action on rhinovirus 3C protease to inhibit viral replication and is used for research on rhinovirus and other viral infections.</p>Formula:C31H39FN4O7Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:598.28028Entecavir hydrate
CAS:<p>Nucleoside reverse transcriptase inhibitor; anti-Hepatitis B virus</p>Formula:C12H15N5O3·xH2OPurity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:277.28 g/molGS 331007
CAS:<p>Anti-viral; RNA polymerase inhibitor; sofosbuvir metabolite</p>Formula:C10H13FN2O5Purity:Min. 95%Color and Shape:Off-White PowderMolecular weight:260.22 g/molSofosbuvir
CAS:<p>Potent inhibitor of viral RNA polymerase called non-structural protein 5B (NS5B). This nucleotide analog is effective against Hepatitis C virus (HCV) infection since it inhibits viral RNA replication. Sofosbuvir is a prodrug and gets triphosphorylated in the liver cells, generating biologically active compound with anti-viral activity.</p>Formula:C22H29FN3O9PPurity:Min. 95%Color and Shape:Off-White PowderMolecular weight:529.45 g/molZalcitabine - Bio-X ™
CAS:<p>Zalcitabine (also known as dideoxycytidine or ddC) is a nucleoside analogue reverse transcriptase inhibitor (NRTI) medication used in the treatment of human immunodeficiency virus (HIV) infections. It works by blocking reverse transcriptase, an enzyme essential for replication of the HIV virus, thereby preventing the virus from multiplying and spreading. Zalcitabine is often used in combination with other antiretroviral drugs to effectively treat HIV/AIDS.</p>Formula:C9H13N3O3Purity:Min. 95%Color and Shape:PowderMolecular weight:211.22 g/molAtazanavir sulfate
CAS:<p>Anti-viral; HIV protease inhibitor</p>Formula:C38H52N6O7·H2SO4Purity:Min. 95%Color and Shape:PowderMolecular weight:802.94 g/molOmbitasvir
CAS:<p>Ombitasvir is a NS5A inhibitor antiviral agent with action on hepatitis C virus replication and is used for treating chronic hepatitis C in combination therapies.</p>Formula:C50H67N7O8Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:894.1 g/molHIV-1 integrase inhibitor
CAS:<p>HIV-1 Integrase Inhibitor is an antiretroviral compound with a mode of action that blocks the viral enzyme integrase, preventing the integration of viral DNA into the host genome. It is used for the treatment of HIV infection.</p>Formula:C11H9N3O4Purity:Min. 95%Color and Shape:PowderMolecular weight:247.21 g/molOseltamivir
CAS:<p>Inhibitor of viral neuraminidase enzyme, effective against influenza A and B viruses. This antiviral compound inhibits neuraminidase-mediated cleavage of host cell sialic acids, which interact with newly synthesised virions from the host cell. This prevents virion budding from the host, resulting in inhibition of virion release and viral infection overall.</p>Formula:C16H28N2O4Purity:Min. 95 Area-%Color and Shape:PowderMolecular weight:312.4 g/molLedipasvir D-tartrate
CAS:<p>Ledipasvir D-tartrate is an antiviral compound, which is a direct-acting antiviral agent used in the treatment of hepatitis C virus (HCV) infection. It originates from synthetic sources designed to inhibit the replication of specific viral proteins. Ledipasvir functions by targeting the NS5A protein of the hepatitis C virus, a key component necessary for viral replication. By binding to this protein, Ledipasvir disrupts and inhibits the HCV replication complex, effectively suppressing the viral load in patients.</p>Formula:C53H60F2N8O12Purity:Min. 95%Molecular weight:1,039.1 g/mol
